IVIG is NOT Contraindicated in Children with Measles
IVIG is specifically indicated and recommended for post-exposure prophylaxis in certain high-risk children who have been exposed to measles, particularly those for whom measles vaccine is contraindicated. This includes immunocompromised children, infants under 6 months of age, and those with severe immunosuppression 1, 2, 1.
When IVIG is Recommended for Measles Exposure
IVIG serves as prophylaxis after measles exposure, not treatment of active measles disease. The key indications are:
High-Risk Groups Requiring IVIG Post-Exposure Prophylaxis:
- Infants <6 months of age who are exposed to measles 2, 3
- Severely immunocompromised children regardless of vaccination status 1, 2, 1
- HIV-infected children with severe immunosuppression (CD4+ counts <750 for infants <12 months, <500 for ages 1-5 years, or <200 for ages ≥6 years) 1
- Children for whom measles vaccine is contraindicated 1
Dosing and Timing:
The recommended dose is 0.5 mL/kg intramuscularly (maximum 15 mL) for immunocompromised children, which corresponds to approximately 82.5 mg/kg of protein 1. For children already receiving regular IGIV therapy (100-400 mg/kg), if the last dose was given within 3 weeks of measles exposure, additional IG may not be needed 1, 2, 1.
IVIG at 400 mg/kg can be used as an alternative when intramuscular injection volume is a concern or for patients ≥30 kg 4, 3, 5. Recent evidence demonstrates that 400 mg/kg IVIG provides protective measles antibody levels (>240 mIU/mL) for at least 2 weeks 4.
Timing is critical: IG should be administered within 6 days of exposure for maximum effectiveness 2, 3. Recent data suggests protection may be strongest when given within the first 3 days 6.
Important Caveats
IVIG is NOT for Routine Sepsis Treatment:
While the question asks about measles specifically, it's worth noting that IVIG is NOT recommended for routine use in children with septic shock or sepsis-associated organ dysfunction 7. This is a completely different clinical scenario from measles post-exposure prophylaxis.
Contraindications to IVIG Itself:
IVIG is contraindicated in patients with:
- History of anaphylactic reactions to human immunoglobulin 4
- IgA deficiency with antibodies to IgA and history of hypersensitivity 4
Vaccine Interference:
After receiving IG for measles prophylaxis, measles-containing vaccine (MMR) should be delayed 5-6 months to avoid interference from passively acquired antibodies 2. The specific interval depends on the dose of IG administered 8.
Clinical Algorithm for Measles-Exposed Children
- Assess immune status and risk factors (age, immunocompetence, vaccination history)
- For immunocompetent children ≥6 months: MMR vaccine within 72 hours is preferred 2, 3
- For high-risk children (immunocompromised, infants <6 months): Administer IG/IGIV within 6 days, preferably within 72 hours 2, 6, 3
- Monitor for 28 days after exposure for measles symptoms 6
Recent effectiveness data shows 99.3% protection with 400 mg/kg IVIG when given appropriately 9, and current IVIG preparations maintain adequate measles antibody concentrations despite concerns about declining titers in the donor population 9, 10, 11.